These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26364600)

  • 1. NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    De Donatis GM; Le Pape E; Pierron A; Cheli Y; Hofman V; Hofman P; Allegra M; Zahaf K; Bahadoran P; Rocchi S; Bertolotto C; Ballotti R; Passeron T
    Oncogene; 2016 May; 35(21):2735-45. PubMed ID: 26364600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.
    Xu Z; Sun Y; Guo Y; Qin G; Mu S; Fan R; Wang B; Gao W; Wu H; Wang G; Zhang Z
    Oncol Rep; 2016 Jun; 35(6):3630-8. PubMed ID: 27109360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.
    Iannetti A; Ledoux AC; Tudhope SJ; Sellier H; Zhao B; Mowla S; Moore A; Hummerich H; Gewurz BE; Cockell SJ; Jat PS; Willmore E; Perkins ND
    PLoS Genet; 2014 Sep; 10(9):e1004642. PubMed ID: 25255445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 as a mediator of treatment resistance in melanoma.
    Tiffen JC; Gallagher SJ; Tseng HY; Filipp FV; Fazekas de St. Groth B; Hersey P
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):500-7. PubMed ID: 27063195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
    Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
    Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.
    Lawrence CL; Baldwin AS
    PLoS One; 2016; 11(10):e0165005. PubMed ID: 27764181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
    Zingg D; Debbache J; Peña-Hernández R; Antunes AT; Schaefer SM; Cheng PF; Zimmerli D; Haeusel J; Calçada RR; Tuncer E; Zhang Y; Bossart R; Wong KK; Basler K; Dummer R; Santoro R; Levesque MP; Sommer L
    Cancer Cell; 2018 Jul; 34(1):69-84.e14. PubMed ID: 30008323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
    Souroullas GP; Jeck WR; Parker JS; Simon JM; Liu JY; Paulk J; Xiong J; Clark KS; Fedoriw Y; Qi J; Burd CE; Bradner JE; Sharpless NE
    Nat Med; 2016 Jun; 22(6):632-40. PubMed ID: 27135738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
    Barsotti AM; Ryskin M; Zhong W; Zhang WG; Giannakou A; Loreth C; Diesl V; Follettie M; Golas J; Lee M; Nichols T; Fan C; Li G; Dann S; Fantin VR; Arndt K; Verhelle D; Rollins RA
    Oncotarget; 2015 Feb; 6(5):2928-38. PubMed ID: 25671303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma.
    Zimmerman SM; Suh E; Smith SR; Souroullas GP
    Cancer Immunol Immunother; 2024 Sep; 73(11):218. PubMed ID: 39235510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer.
    Kaur P; Verma S; Kushwaha PP; Gupta S
    Cancer Lett; 2023 Apr; 560():216143. PubMed ID: 36958695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
    Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JS; Kuntz KK; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
    PLoS One; 2016; 11(7):e0158888. PubMed ID: 27391784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained activation of NF-κB through constitutively active IKKβ leads to senescence bypass in murine dermal fibroblasts.
    Harada M; Su-Harada K; Kimura T; Ono K; Ashida N
    Cell Cycle; 2024 Feb; 23(3):308-327. PubMed ID: 38461418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
    Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
    Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.
    Tiffen J; Gallagher SJ; Filipp F; Gunatilake D; Emran AA; Cullinane C; Dutton-Register K; Aoude L; Hayward N; Chatterjee A; Rodger EJ; Eccles MR; Hersey P
    J Invest Dermatol; 2020 Dec; 140(12):2442-2454.e5. PubMed ID: 32360600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezh2
    Zimmerman SM; Nixon SJ; Chen PY; Raj L; Smith SR; Paolini RL; Lin PN; Souroullas GP
    Oncogene; 2022 Nov; 41(46):4983-4993. PubMed ID: 36220978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.